Tirzepatide

Research overview

Tirzepatide is a dual GIP/GLP-1 receptor agonist research peptide family. Choose the vial strength that matches the qualified research workflow; all variants are listed for research-use contexts only.

Available strengths

• 5mg, 10mg, 15mg, 20mg, 25mg, and 30mg vial options.
• Variation pricing updates automatically after a strength is selected.
• Variation imagery reflects the selected labeled strength where available.

Catalog benefits

• One clean product page instead of separate listings for each strength.
• Native WooCommerce variation handling for cart and checkout.
• Consistent research-use labeling and handling language.

Research-use notice: This product is not intended to diagnose, treat, cure, or prevent disease and is not for human or animal consumption.